NovaBridge Biosciences (NBP)
1.02
-0.05
(-4.67%)
USD |
NASDAQ |
Nov 03, 14:20
NovaBridge Biosciences EPS Diluted (Quarterly) : -0.268 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.268 |
| September 30, 2025 | -0.0677 |
| June 30, 2025 | -0.0676 |
| March 31, 2025 | -0.0386 |
| December 31, 2020 | 2.192 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.0264 |
| December 31, 2019 | -0.9311 |
| September 30, 2019 | -0.6029 |
| December 31, 2018 | -0.3068 |
| September 30, 2018 | -0.2848 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Xencor, Inc. | -0.2864 |
| Arrivent BioPharma, Inc. | -1.048 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 15.72 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -73.18M |
| Total Expenses (Quarterly) | 30.92M |